Profile data is unavailable for this security.
About the company
Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.
- Revenue in USD (TTM)225.44m
- Net income in USD-54.02m
- Incorporated2021
- Employees430.00
- LocationParagon 28 Inc14445 Grasslands DriveENGLEWOOD 80112United StatesUSA
- Phone+1 (720) 912-1332
- Fax+1 (302) 655-5049
- Websitehttps://paragon28.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZimVie Inc | 455.22m | -51.16m | 456.27m | 2.60k | -- | 1.17 | -- | 1.00 | -1.92 | -14.01 | 17.11 | 14.24 | 0.3299 | 1.09 | 3.73 | 175,085.40 | -3.71 | -- | -4.28 | -- | 63.05 | 65.51 | -11.24 | -8.73 | 2.23 | -0.343 | 0.5673 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| MaxCyte Inc | 44.05m | -36.57m | 474.63m | 143.00 | -- | 2.09 | -- | 10.77 | -0.3532 | -0.3532 | 0.4253 | 2.17 | 0.1633 | 0.463 | 5.77 | 308,067.80 | -13.56 | -13.18 | -14.36 | -14.33 | 88.32 | 88.79 | -83.01 | -62.96 | 12.37 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| Surmodics Inc | 142.96m | 13.50m | 487.98m | 376.00 | 35.66 | 3.94 | 21.94 | 3.41 | 0.9597 | 0.9597 | 10.14 | 8.69 | 0.8194 | 2.05 | 6.66 | 380,220.80 | 7.74 | -1.85 | 8.69 | -2.18 | 79.11 | 82.93 | 9.44 | -2.98 | 3.59 | 9.66 | 0.1921 | -- | 32.65 | 10.27 | 94.37 | -- | -27.02 | -- |
| Nano-X Imaging Ltd | 9.91m | -60.78m | 496.41m | 164.00 | -- | 2.54 | -- | 50.12 | -1.08 | -1.08 | 0.1757 | 3.38 | 0.0419 | -- | 8.05 | 60,396.34 | -25.72 | -30.98 | -28.14 | -35.10 | -66.55 | -- | -613.59 | -1,527.24 | 5.56 | -- | 0.0175 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Bioventus Inc | 522.74m | -21.65m | 503.96m | 995.00 | -- | 2.94 | 19.75 | 0.9641 | -0.3438 | -0.3438 | 8.30 | 2.16 | 0.6217 | 1.95 | 4.28 | 538,910.30 | -3.23 | -5.52 | -4.47 | -7.27 | 65.55 | 68.25 | -5.20 | -10.94 | 0.9745 | 1.03 | 0.6428 | -- | 0.0445 | 9.93 | 6.91 | -- | 23.51 | -- |
| Pacific Biosciences of California Inc | 200.43m | -296.90m | 528.37m | 796.00 | -- | 0.8139 | -- | 2.64 | -1.14 | -1.14 | 0.7695 | 2.38 | 0.1124 | 2.21 | 6.69 | 251,797.70 | -16.65 | -16.19 | -18.40 | -17.81 | 28.81 | 37.35 | -148.13 | -136.21 | 8.36 | -21.84 | 0.5791 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Iradimed Corp | 67.69m | 17.92m | 534.68m | 148.00 | 30.00 | 7.02 | 28.54 | 7.90 | 1.41 | 1.41 | 5.31 | 6.01 | 0.8273 | 1.67 | 5.51 | 457,333.40 | 21.91 | 13.16 | 24.02 | 14.58 | 76.57 | 76.55 | 26.48 | 21.46 | 7.77 | -- | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| SI-Bone Inc | 144.05m | -43.12m | 552.56m | 344.00 | -- | 3.33 | -- | 3.84 | -1.08 | -1.08 | 3.61 | 4.03 | 0.7728 | 1.62 | 6.44 | 418,735.50 | -23.13 | -27.88 | -25.72 | -30.94 | 78.10 | 85.03 | -29.93 | -51.09 | 8.75 | -- | 0.1791 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Orthofix Medical Inc | 760.05m | -126.48m | 558.06m | 1.63k | -- | 0.9754 | -- | 0.7343 | -3.40 | -3.40 | 20.42 | 15.24 | 0.8338 | 1.16 | 6.36 | 465,143.80 | -13.87 | -8.88 | -16.48 | -10.96 | 66.20 | 72.37 | -16.64 | -9.28 | 1.19 | -8.38 | 0.194 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Varex Imaging Corp | 855.80m | 41.90m | 600.41m | 2.30k | 24.31 | 1.04 | 7.80 | 0.7016 | 0.604 | 0.604 | 16.18 | 14.10 | 0.7008 | 1.94 | 5.50 | 356,583.30 | 3.47 | 0.9913 | 4.03 | 1.18 | 32.39 | 31.70 | 4.95 | 1.36 | 2.37 | 2.57 | 0.4292 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
| Fulgent Genetics Inc | 287.53m | -165.95m | 632.60m | 1.18k | -- | 0.5592 | -- | 2.20 | -5.57 | -5.57 | 9.64 | 37.80 | 0.2206 | -- | 6.01 | 242,846.30 | -13.29 | 16.70 | -14.16 | 18.37 | 37.47 | 67.89 | -60.25 | 29.06 | -- | -- | 0.0014 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
| Paragon 28 Inc | 225.44m | -54.02m | 636.24m | 430.00 | -- | 3.87 | -- | 2.82 | -0.6536 | -0.6536 | 2.73 | 1.98 | 0.6956 | 0.5405 | 5.82 | 524,267.40 | -16.67 | -- | -20.52 | -- | 79.21 | -- | -23.96 | -- | 1.78 | -6.45 | 0.4018 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Pulse Biosciences Inc | 0.00 | -42.55m | 659.94m | 56.00 | -- | 18.19 | -- | -- | -0.8152 | -0.8152 | 0.00 | 0.6571 | 0.00 | -- | -- | 0.00 | -71.28 | -93.21 | -79.29 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| Embecta Corp | 1.13bn | 70.20m | 749.14m | 2.20k | 10.68 | -- | 7.08 | 0.6615 | 1.22 | 1.22 | 19.62 | -13.35 | 0.94 | 2.51 | 15.86 | 514,772.70 | 5.83 | -- | 8.06 | -- | 65.57 | -- | 6.20 | -- | 1.79 | 1.51 | 1.89 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Orthopediatrics Corp | 161.83m | -21.97m | 756.09m | 247.00 | -- | 2.02 | -- | 4.67 | -0.9647 | -0.9647 | 7.11 | 15.74 | 0.3748 | 0.4247 | 5.13 | 655,178.10 | -5.09 | -5.40 | -5.62 | -5.93 | 74.07 | 75.09 | -13.58 | -15.92 | 1.99 | -- | 0.0271 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| Cytek Biosciences Inc | 200.79m | -11.51m | 777.14m | 637.00 | -- | 1.98 | -- | 3.87 | -0.0856 | -0.0856 | 1.50 | 2.99 | 0.395 | 1.44 | 4.30 | 297,020.70 | -2.26 | -- | -2.54 | -- | 55.48 | -- | -5.73 | -- | 6.01 | -- | 0.0086 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
Data as of May 24 2024. Currency figures normalised to Paragon 28 Inc's reporting currency: US Dollar USD
23.54%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Light Asset Management LLCas of 31 Mar 2024 | 3.80m | 4.59% |
| Braidwell LPas of 31 Mar 2024 | 3.37m | 4.06% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 3.06m | 3.70% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 2.00m | 2.42% |
| Bleichroeder LPas of 31 Mar 2024 | 1.76m | 2.13% |
| Citadel Advisors LLCas of 31 Mar 2024 | 1.31m | 1.59% |
| Janus Henderson Investors US LLCas of 31 Mar 2024 | 1.19m | 1.43% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.15m | 1.38% |
| Degroof Petercam Asset Management SAas of 31 Mar 2024 | 974.00k | 1.18% |
| Geode Capital Management LLCas of 31 Mar 2024 | 879.61k | 1.06% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
